Literature DB >> 17631148

Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia.

Pranavkumar Shivakumar1, Gregg Sabla, Sujit Mohanty, Monica McNeal, Richard Ward, Keith Stringer, Charles Caldwell, Claire Chougnet, Jorge A Bezerra.   

Abstract

BACKGROUND & AIMS: Lymphocytes populate the livers of infants with biliary atresia, but it is unknown whether neonatal lymphocytes regulate pathogenesis of disease. Here, we investigate this question by examining the role of T lymphocytes in the destruction of extrahepatic bile ducts of neonatal mice using an experimental model of biliary atresia.
METHODS: Inoculation of neonatal mice with rhesus rotavirus followed by multistaining flow cytometry to quantify expression of interferon-gamma by hepatic lymphocytes, and real-time polymerase chain reaction for mRNA expression of pro-inflammatory cytokines. This was followed by determining the consequences of antibody-mediated depletion of lymphocyte subtypes on the development of biliary obstruction, and coculture and cell transfer experiments to investigate the effector role of lymphocyte subtypes on neonatal biliary disease.
RESULTS: Rotavirus infection results in overexpression of interferon-gamma by neonatal hepatic T cells. Among these cells, depletion of CD4(+) cells did not change the course of inflammatory injury and obstruction of neonatal bile ducts. In contrast, loss of CD8(+) cells remarkably suppressed duct injury, prevented luminal obstruction, and restored bile flow. Coculture experiments showed that rotavirus-primed, but not naïve, CD8(+) cells were cytotoxic to cholangiocytes. In adoptive transfer experiments, we found that primed CD8(+) cells preferentially homed to extrahepatic bile ducts of neonatal mice and invaded their epithelial lining.
CONCLUSIONS: Primed neonatal CD8(+) cells can activate a pro-inflammatory program, target diseased and healthy duct epithelium, and drive the phenotypic expression of biliary atresia, thus constituting a potential therapeutic target to halt disease progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17631148      PMCID: PMC2013308          DOI: 10.1053/j.gastro.2007.04.031

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  27 in total

Review 1.  Development of neonatal Th1/Th2 function.

Authors:  B Adkins
Journal:  Int Rev Immunol       Date:  2000       Impact factor: 5.311

2.  Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization.

Authors:  D E Hassett; J Zhang; M Slifka; J L Whitton
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 3.  Pathogenesis and outcome of biliary atresia: current concepts.

Authors:  Ronald J Sokol; Cara Mack; Michael R Narkewicz; Frederick M Karrer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-07       Impact factor: 2.839

Review 4.  Neonatal adaptive immunity comes of age.

Authors:  Becky Adkins; Claude Leclerc; Stuart Marshall-Clarke
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

5.  IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2.

Authors:  Lequn Li; Hyun-Hee Lee; J Jeremiah Bell; Randal K Gregg; Jason S Ellis; Andre Gessner; Habib Zaghouani
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

6.  Perforin and Fas/Fas ligand-mediated cytotoxicity in acute and chronic woodchuck viral hepatitis.

Authors:  P D Hodgson; M D Grant; T I Michalak
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

7.  Genetic induction of proinflammatory immunity in children with biliary atresia.

Authors:  Jorge A Bezerra; Greg Tiao; Frederick C Ryckman; Maria Alonso; Gregg E Sabla; Benjamin Shneider; Ronald J Sokol; Bruce J Aronow
Journal:  Lancet       Date:  2002-11-23       Impact factor: 79.321

8.  Identification, genomic organization, chromosomal mapping and mutation analysis of the human INV gene, the ortholog of a murine gene implicated in left-right axis development and biliary atresia.

Authors:  Patric Schön; Ken Tsuchiya; Didier Lenoir; Toshio Mochizuki; Cécile Guichard; Setsuo Takai; Amit K Maiti; Hiroshi Nihei; Johan Weil; Takahiko Yokoyama; Patrice Bouvagnet
Journal:  Hum Genet       Date:  2001-12-18       Impact factor: 4.132

9.  Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation.

Authors:  Cara L Mack; Rebecca M Tucker; Ronald J Sokol; Frederick M Karrer; Brian L Kotzin; Peter F Whitington; Stephen D Miller
Journal:  Pediatr Res       Date:  2004-05-05       Impact factor: 3.756

Review 10.  T cell immunity in neonates.

Authors:  A M Garcia; S A Fadel; S Cao; M Sarzotti
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

View more
  55 in total

1.  MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia.

Authors:  Nicholas J Hand; Amber M Horner; Zankhana R Master; LaTasha A Boateng; Claire LeGuen; Marina Uvaydova; Joshua R Friedman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-02       Impact factor: 2.839

2.  Macrophages are targeted by rotavirus in experimental biliary atresia and induce neutrophil chemotaxis by Mip2/Cxcl2.

Authors:  Sujit K Mohanty; Cláudia A P Ivantes; Reena Mourya; Cristina Pacheco; Jorge A Bezerra
Journal:  Pediatr Res       Date:  2010-04       Impact factor: 3.756

3.  Dendritic cells regulate natural killer cell activation and epithelial injury in experimental biliary atresia.

Authors:  Vijay Saxena; Pranavkumar Shivakumar; Gregg Sabla; Reena Mourya; Claire Chougnet; Jorge A Bezerra
Journal:  Sci Transl Med       Date:  2011-09-28       Impact factor: 17.956

4.  Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype.

Authors:  Jun Li; Kazuhiko Bessho; Pranavkumar Shivakumar; Reena Mourya; Sujit Kumar Mohanty; Jorge L Dos Santos; Irene K Miura; Gilda Porta; Jorge A Bezerra
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

5.  Corticosteroid treatment in biliary atresia: Tonic or toast?

Authors:  Ronald J Sokol
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

6.  Regulation of epithelial injury and bile duct obstruction by NLRP3, IL-1R1 in experimental biliary atresia.

Authors:  Li Yang; Tatsuki Mizuochi; Pranavkumar Shivakumar; Reena Mourya; Zhenhua Luo; Sridevi Gutta; Jorge A Bezerra
Journal:  J Hepatol       Date:  2018-06-08       Impact factor: 25.083

7.  Swiss outcomes in biliary atresia: are there lessons to be learned?

Authors:  Ronald J Sokol
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-03       Impact factor: 2.839

8.  RRAS: A key regulator and an important prognostic biomarker in biliary atresia.

Authors:  Rui Zhao; Hao Li; Chun Shen; Shan Zheng
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

Review 9.  Biliary atresia: will blocking inflammation tame the disease?

Authors:  Kazuhiko Bessho; Jorge A Bezerra
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

10.  Perforin and granzymes work in synergy to mediate cholangiocyte injury in experimental biliary atresia.

Authors:  Pranavkumar Shivakumar; Reena Mourya; Jorge A Bezerra
Journal:  J Hepatol       Date:  2013-10-02       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.